{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:02:09Z","timestamp":1792839729546,"version":"4.5.0"},"reference-count":159,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:00:00Z","timestamp":1743724800000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>This review provides a broad overview of lessons learned in the five years since COVID-19 was identified. It is a bimodal disease, starting with an initially virus-driven phase, followed by resolution or ensuing inappropriate immune activation causing severe inflammation that is no longer strictly virus dependent. Humoral immunity is beneficial for preventing or attenuating the early stage, without benefit once the later stage begins. Neutralizing antibodies elicited by natural infection or vaccination are short-lived and highly vulnerable to viral sequence variation. By contrast, cellular immunity, particularly the CD8+ T cell arm, has a role in preventing or attenuating severe disease, is far less susceptible to viral variation, and is longer-lived than antibodies. Finally, an ill-defined phenomenon of prolonged symptoms after acute infection, termed \u201clong COVID,\u201d is poorly understood but may involve various immunologic defects that are hyperactivating or immunosuppressive. Remaining issues include needing to better understand the immune dysregulation of severe disease to allow more tailored therapeutic interventions, developing antibody strategies that cope with the viral spike sequence variability, prolonging vaccine efficacy, and unraveling the mechanisms of long COVID to design therapeutic approaches.<\/jats:p>","DOI":"10.1093\/jimmun\/vkaf033","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:07:23Z","timestamp":1743725243000},"page":"1095-1104","source":"Crossref","is-referenced-by-count":14,"title":["The immunopathogenesis of SARS-CoV-2 infection: Overview of lessons learned in the first 5 years"],"prefix":"10.1093","volume":"214","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1970-8992","authenticated-orcid":false,"given":"Otto O","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles , Los Angeles, CA,","place":["United States"]},{"name":"Department of Microbiology, Immunology and Molecular Genetics, David Geffen School of Medicine, University of California, Los Angeles , Los Angeles, CA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,4,3]]},"reference":[{"key":"2025063003524525500_vkaf033-B1","author":"WHO","year":"2024"},{"key":"2025063003524525500_vkaf033-B2","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41586-022-05522-2","article-title":"The WHO estimates of excess mortality associated with the COVID-19 pandemic","volume":"613","author":"Msemburi","year":"2023","journal-title":"Nature"},{"key":"2025063003524525500_vkaf033-B3","doi-asserted-by":"crossref","first-page":"5337","DOI":"10.1038\/s41467-020-19146-5","article-title":"Antibody-mediated disruption of the SARS-CoV-2 spike glycoprotein","volume":"11","author":"Wrobel","year":"2020","journal-title":"Nat Commun"},{"key":"2025063003524525500_vkaf033-B4","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1056\/NEJMp2022269","article-title":"Covid-19, Ebola, and HIV\u2014leveraging lessons to maximize impact","volume":"383","author":"Celum","year":"2020","journal-title":"N Engl J Med"},{"key":"2025063003524525500_vkaf033-B5","doi-asserted-by":"crossref","first-page":"e26039","DOI":"10.1002\/jia2.26039","article-title":"Forty years of investment in HIV research: progress towards ending the HIV pandemic and preparation for future pandemics","volume":"25","author":"Read","year":"2022","journal-title":"J Int AIDS Soc"},{"key":"2025063003524525500_vkaf033-B6","doi-asserted-by":"crossref","first-page":"m1966","DOI":"10.1136\/bmj.m1966","article-title":"Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study","volume":"369","author":"Petrilli","year":"2020","journal-title":"BMJ"},{"key":"2025063003524525500_vkaf033-B7","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","volume":"8","author":"Yang","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2025063003524525500_vkaf033-B8","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1093\/cid\/ciaa657","article-title":"Hospitalized patients with COVID-19 and human immunodeficiency virus: a case series","volume":"71","author":"Childs","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2025063003524525500_vkaf033-B9","doi-asserted-by":"crossref","first-page":"E1155","DOI":"10.1503\/cmaj.220620","article-title":"Severity of COVID-19 among solid organ transplant recipients in Canada, 2020","volume":"194","author":"Hall","year":"2022","journal-title":"CMAJ"},{"key":"2025063003524525500_vkaf033-B10","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1056\/NEJMc2007617","article-title":"Children with Covid-19 in pediatric emergency departments in Italy","volume":"383","author":"Parri","year":"2020","journal-title":"N Engl J Med"},{"key":"2025063003524525500_vkaf033-B11","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00431-013-2023-6","article-title":"The burden of seasonal and pandemic influenza in infants and children","volume":"173","author":"Ruf","year":"2014","journal-title":"Eur J Pediatr"},{"key":"2025063003524525500_vkaf033-B12","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","article-title":"Factors associated with COVID-19-related death using OpenSAFELY","volume":"584","author":"Williamson","year":"2020","journal-title":"Nature"},{"key":"2025063003524525500_vkaf033-B13","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.orcp.2020.06.001","article-title":"Obesity is the comorbidity more strongly associated for Covid-19 in Mexico. A case-control study","volume":"14","author":"Hernandez-Garduno","year":"2020","journal-title":"Obes Res Clin Pract"},{"key":"2025063003524525500_vkaf033-B14","doi-asserted-by":"crossref","first-page":"154262","DOI":"10.1016\/j.metabol.2020.154262","article-title":"Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York","volume":"108","author":"Palaiodimos","year":"2020","journal-title":"Metabolism"},{"key":"2025063003524525500_vkaf033-B15","doi-asserted-by":"crossref","first-page":"m2648","DOI":"10.1136\/bmj.m2648","article-title":"Dexamethasone in the management of covid -19","volume":"370","author":"Johnson","year":"2020","journal-title":"BMJ"},{"key":"2025063003524525500_vkaf033-B16","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa2001316","article-title":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia","volume":"382","author":"Li","year":"2020","journal-title":"N Engl J Med"},{"key":"2025063003524525500_vkaf033-B17","doi-asserted-by":"crossref","first-page":"e2228008","DOI":"10.1001\/jamanetworkopen.2022.28008","article-title":"Incubation period of COVID-19 caused by unique SARS-CoV-2 strains: a systematic review and meta-analysis","volume":"5","author":"Wu","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2025063003524525500_vkaf033-B18","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"2025063003524525500_vkaf033-B19","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/s41591-020-1051-9","article-title":"An inflammatory cytokine signature predicts COVID-19 severity and survival","volume":"26","author":"Del Valle","year":"2020","journal-title":"Nat Med"},{"key":"2025063003524525500_vkaf033-B20","doi-asserted-by":"crossref","first-page":"599729","DOI":"10.3389\/fphys.2020.599729","article-title":"Biological context linking hypertension and higher risk for COVID-19 severity","volume":"11","author":"Tavares","year":"2020","journal-title":"Front Physiol"},{"key":"2025063003524525500_vkaf033-B21","doi-asserted-by":"crossref","first-page":"851","DOI":"10.5114\/aoms.2016.58928","article-title":"Obesity and inflammation: the linking mechanism and the complications","volume":"13","author":"Ellulu","year":"2017","journal-title":"Arch Med Sci"},{"key":"2025063003524525500_vkaf033-B22","doi-asserted-by":"crossref","first-page":"e250","DOI":"10.1093\/cid\/ciac724","article-title":"Infectious diseases society of america guidelines on the treatment and management of patients with COVID-19 (September 2022)","volume":"78","author":"Bhimraj","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2025063003524525500_vkaf033-B23","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa2118542","article-title":"Oral nirmatrelvir for high-risk, nonhospitalized adults with Covid-19","volume":"386","author":"Hammond","year":"2022","journal-title":"N Engl J Med"},{"key":"2025063003524525500_vkaf033-B24","first-page":"100694","article-title":"Efficacy and safety of Paxlovid in severe adult patients with SARS-Cov-2 infection: a multicenter randomized controlled study","volume":"33","author":"Liu","year":"2023","journal-title":"Lancet Reg Health West Pac"},{"key":"2025063003524525500_vkaf033-B25","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa2035002","article-title":"REGN-COV2, a neutralizing antibody cocktail, in outpatients with covid-19","volume":"384","author":"Weinreich","year":"2021","journal-title":"N Engl J Med"},{"key":"2025063003524525500_vkaf033-B26","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMoa2033130","article-title":"A neutralizing monoclonal antibody for hospitalized patients with covid-19","volume":"384","author":"Lundgren","year":"2021","journal-title":"N Engl J Med"},{"key":"2025063003524525500_vkaf033-B27","doi-asserted-by":"crossref","first-page":"28336","DOI":"10.1073\/pnas.2018030117","article-title":"Transcriptional and proteomic insights into the host response in fatal COVID-19 cases","volume":"117","author":"Wu","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025063003524525500_vkaf033-B28","doi-asserted-by":"crossref","first-page":"e290","DOI":"10.1016\/S2666-5247(20)30144-0","article-title":"Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study","volume":"1","author":"Schurink","year":"2020","journal-title":"Lancet Microbe"},{"key":"2025063003524525500_vkaf033-B29","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with Covid-19","volume":"384","author":"Group","year":"2021","journal-title":"N Engl J Med"},{"key":"2025063003524525500_vkaf033-B30","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa2031994","article-title":"Baricitinib plus remdesivir for hospitalized adults with covid-19","volume":"384","author":"Kalil","year":"2021","journal-title":"N Engl J Med"},{"key":"2025063003524525500_vkaf033-B31","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/S2213-2600(21)00331-3","article-title":"Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial","volume":"9","author":"Marconi","year":"2021","journal-title":"Lancet Respir Med"},{"key":"2025063003524525500_vkaf033-B32","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa2028700","article-title":"Tocilizumab in hospitalized patients with severe covid-19 pneumonia","volume":"384","author":"Rosas","year":"2021","journal-title":"N Engl J Med"},{"key":"2025063003524525500_vkaf033-B33","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"2025063003524525500_vkaf033-B34","doi-asserted-by":"crossref","first-page":"13958","DOI":"10.1074\/jbc.AC120.013788","article-title":"Inhibition of SARS-CoV-2 by type I and type III interferons","volume":"295","author":"Felgenhauer","year":"2020","journal-title":"J Biol Chem"},{"key":"2025063003524525500_vkaf033-B35","doi-asserted-by":"crossref","first-page":"7092","DOI":"10.1038\/s41467-021-27318-0","article-title":"Delayed induction of type I and III interferons mediates nasal epithelial cell permissiveness to SARS-CoV-2","volume":"12","author":"Hatton","year":"2021","journal-title":"Nat Commun"},{"key":"2025063003524525500_vkaf033-B36","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1126\/science.abc6027","article-title":"Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients","volume":"369","author":"Hadjadj","year":"2020","journal-title":"Science"},{"key":"2025063003524525500_vkaf033-B37","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa2209760","article-title":"Early treatment with pegylated interferon lambda for Covid-19","volume":"388","author":"Reis","year":"2023","journal-title":"N Engl J Med"},{"key":"2025063003524525500_vkaf033-B38","doi-asserted-by":"crossref","first-page":"eabd4585","DOI":"10.1126\/science.abd4585","article-title":"Autoantibodies against type I IFNs in patients with life-threatening COVID-19","volume":"370","author":"Bastard","year":"2020","journal-title":"Science"},{"key":"2025063003524525500_vkaf033-B39","doi-asserted-by":"crossref","first-page":"eabd4570","DOI":"10.1126\/science.abd4570","article-title":"Inborn errors of type I IFN immunity in patients with life-threatening COVID-19","volume":"370","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"2025063003524525500_vkaf033-B40","doi-asserted-by":"crossref","first-page":"e109622","DOI":"10.15252\/embj.2021109622","article-title":"TLR2 and TLR7 mediate distinct immunopathological and antiviral plasmacytoid dendritic cell responses to SARS-CoV-2 infection","volume":"41","author":"van der Sluis","year":"2022","journal-title":"EMBO J"},{"key":"2025063003524525500_vkaf033-B41","doi-asserted-by":"crossref","first-page":"e06187","DOI":"10.1016\/j.heliyon.2021.e06187","article-title":"SARS-CoV-2 spike protein S1 subunit induces pro-inflammatory responses via toll-like receptor 4 signaling in murine and human macrophages","volume":"7","author":"Shirato","year":"2021","journal-title":"Heliyon"},{"key":"2025063003524525500_vkaf033-B42","doi-asserted-by":"crossref","first-page":"948770","DOI":"10.3389\/fmicb.2022.948770","article-title":"Toll-like receptor signaling in severe acute respiratory syndrome coronavirus 2-induced innate immune responses and the potential application value of toll-like receptor immunomodulators in patients with coronavirus disease 2019","volume":"13","author":"Dai","year":"2022","journal-title":"Front Microbiol"},{"key":"2025063003524525500_vkaf033-B43","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1136\/gutjnl-2020-323020","article-title":"Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19","volume":"70","author":"Yeoh","year":"2021","journal-title":"Gut"},{"key":"2025063003524525500_vkaf033-B44","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1053\/j.gastro.2020.05.048","article-title":"Alterations in gut microbiota of patients with COVID-19 during time of hospitalization","volume":"159","author":"Zuo","year":"2020","journal-title":"Gastroenterology"},{"key":"2025063003524525500_vkaf033-B45","doi-asserted-by":"crossref","first-page":"e0068024","DOI":"10.1128\/spectrum.00680-24","article-title":"SARS-CoV-2 infection is associated with intestinal permeability, systemic inflammation, and microbial dysbiosis in hospitalized patients","volume":"12","author":"Basting","year":"2024","journal-title":"Microbiol Spectr"},{"key":"2025063003524525500_vkaf033-B46","doi-asserted-by":"crossref","first-page":"779064","DOI":"10.3389\/fimmu.2021.779064","article-title":"Plasma markers of disrupted gut permeability in severe COVID-19 patients","volume":"12","author":"Giron","year":"2021","journal-title":"Front Immunol"},{"key":"2025063003524525500_vkaf033-B47","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1126\/science.abc1669","article-title":"SARS-CoV-2 productively infects human gut enterocytes","volume":"369","author":"Lamers","year":"2020","journal-title":"Science"},{"key":"2025063003524525500_vkaf033-B48","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1186\/s12889-020-09826-8","article-title":"COVID-19 mortality risk for older men and women","volume":"20","author":"Yanez","year":"2020","journal-title":"BMC Public Health"},{"key":"2025063003524525500_vkaf033-B49","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s00277-021-04489-w","article-title":"Association between ABO blood types and coronavirus disease 2019 (COVID-19), genetic associations, and underlying molecular mechanisms: a literature review of 23 studies","volume":"100","author":"Zhang","year":"2021","journal-title":"Ann Hematol"},{"key":"2025063003524525500_vkaf033-B50","doi-asserted-by":"crossref","first-page":"104485","DOI":"10.1016\/j.meegid.2020.104485","article-title":"Association between ABO blood groups and COVID-19 infection, severity and demise: a systematic review and meta-analysis","volume":"84","author":"Wu","year":"2020","journal-title":"Infect Genet Evol"},{"key":"2025063003524525500_vkaf033-B51","doi-asserted-by":"crossref","first-page":"eabm5505","DOI":"10.1126\/sciimmunol.abm5505","article-title":"Innate immunological pathways in COVID-19 pathogenesis","volume":"7","author":"Paludan","year":"2022","journal-title":"Sci Immunol"},{"key":"2025063003524525500_vkaf033-B52","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"2025063003524525500_vkaf033-B53","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1172\/JCI137244","article-title":"Clinical and immunological features of severe and moderate coronavirus disease 2019","volume":"130","author":"Chen","year":"2020","journal-title":"J Clin Invest"},{"key":"2025063003524525500_vkaf033-B54","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/s41587-020-0602-4","article-title":"COVID-19 severity correlates with airway epithelium\u2013immune cell interactions identified by single-cell analysis","volume":"38","author":"Chua","year":"2020","journal-title":"Nat Biotechnol"},{"key":"2025063003524525500_vkaf033-B55","doi-asserted-by":"crossref","first-page":"25018","DOI":"10.1073\/pnas.2010540117","article-title":"Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients","volume":"117","author":"Holter","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025063003524525500_vkaf033-B56","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1038\/s41591-020-1038-6","article-title":"A dynamic COVID-19 immune signature includes associations with poor prognosis","volume":"26","author":"Laing","year":"2020","journal-title":"Nat Med"},{"key":"2025063003524525500_vkaf033-B57","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.medj.2021.03.013","article-title":"Alterations in T and B cell function persist in convalescent COVID-19 patients","volume":"2","author":"Shuwa","year":"2021","journal-title":"Med"},{"key":"2025063003524525500_vkaf033-B58","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3389\/fimmu.2020.00827","article-title":"Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19)","volume":"11","author":"Diao","year":"2020","journal-title":"Front Immunol"},{"key":"2025063003524525500_vkaf033-B59","doi-asserted-by":"crossref","first-page":"108486","DOI":"10.1016\/j.clim.2020.108486","article-title":"Selective CD8 cell reduction by SARS-CoV-2 is associated with a worse prognosis and systemic inflammation in COVID-19 patients","volume":"217","author":"Urra","year":"2020","journal-title":"Clin Immunol"},{"key":"2025063003524525500_vkaf033-B60","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/s41591-020-0901-9","article-title":"Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19","volume":"26","author":"Liao","year":"2020","journal-title":"Nat Med"},{"key":"2025063003524525500_vkaf033-B61","doi-asserted-by":"crossref","first-page":"735922","DOI":"10.3389\/fimmu.2021.735922","article-title":"COVID-19 lung pathogenesis in SARS-CoV-2 autopsy cases","volume":"12","author":"Valdebenito","year":"2021","journal-title":"Front Immunol"},{"key":"2025063003524525500_vkaf033-B62","doi-asserted-by":"crossref","DOI":"10.1126\/science.abc8511","article-title":"Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications","volume":"369","author":"Mathew","year":"2020","journal-title":"Science"},{"key":"2025063003524525500_vkaf033-B63","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1038\/s41467-020-17292-4","article-title":"Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia","volume":"11","author":"De Biasi","year":"2020","journal-title":"Nat Commun"},{"key":"2025063003524525500_vkaf033-B64","doi-asserted-by":"crossref","first-page":"e150175","DOI":"10.1172\/JCI150175","article-title":"Impaired humoral and cellular immunity after SARS-CoV-2 BNT162b2 (tozinameran) prime-boost vaccination in kidney transplant recipients","volume":"131","author":"Sattler","year":"2021","journal-title":"J Clin Invest"},{"key":"2025063003524525500_vkaf033-B65","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1093\/nsr\/nwaa041","article-title":"Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients","volume":"7","author":"Zhou","year":"2020","journal-title":"Natl Sci Rev"},{"key":"2025063003524525500_vkaf033-B66","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abf6692","article-title":"Clonal expansion and activation of tissue-resident memory-like Th17 cells expressing GM-CSF in the lungs of severe COVID-19 patients","volume":"6","author":"Zhao","year":"2021","journal-title":"Sci Immunol"},{"key":"2025063003524525500_vkaf033-B67","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/imm.13223","article-title":"Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China","volume":"160","author":"Tan","year":"2020","journal-title":"Immunology"},{"key":"2025063003524525500_vkaf033-B68","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.cell.2020.11.007","article-title":"Baricitinib treatment resolves lower-airway macrophage inflammation and neutrophil recruitment in SARS-CoV-2-infected rhesus macaques","volume":"184","author":"Hoang","year":"2021","journal-title":"Cell"},{"key":"2025063003524525500_vkaf033-B69","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1002\/cpmc.100","article-title":"SARS-CoV-2 seroconversion in humans: a detailed protocol for a serological assay","volume":"57","author":"Stadlbauer","year":"2020","journal-title":"Curr Protoc Microbiol"},{"key":"2025063003524525500_vkaf033-B70","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/s41591-020-0913-5","article-title":"A serological assay to detect SARS-CoV-2 seroconversion in humans","volume":"26","author":"Amanat","year":"2020","journal-title":"Nat Med"},{"key":"2025063003524525500_vkaf033-B71","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1093\/cid\/ciaa344","article-title":"Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019","volume":"71","author":"Zhao","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2025063003524525500_vkaf033-B72","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/cid\/ciaa979","article-title":"Magnitude and kinetics of anti-severe acute respiratory syndrome coronavirus 2 antibody responses and their relationship to disease severity","volume":"72","author":"Lynch","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2025063003524525500_vkaf033-B73","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41423-020-0474-z","article-title":"Serum IgA, IgM, and IgG responses in COVID-19","volume":"17","author":"Ma","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"2025063003524525500_vkaf033-B74","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41586-021-03696-9","article-title":"Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection","volume":"595","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"2025063003524525500_vkaf033-B75","doi-asserted-by":"crossref","first-page":"11180","DOI":"10.1021\/acsnano.1c03972","article-title":"Primary, recall, and decay kinetics of SARS-CoV-2 vaccine antibody responses","volume":"15","author":"Ibarrondo","year":"2021","journal-title":"ACS Nano"},{"key":"2025063003524525500_vkaf033-B76","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1001\/jama.2021.8828","article-title":"Effect of bamlanivimab vs placebo on incidence of COVID-19 among residents and staff of skilled nursing and assisted living facilities: a randomized clinical trial","volume":"326","author":"Cohen","year":"2021","journal-title":"JAMA"},{"key":"2025063003524525500_vkaf033-B77","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.cell.2020.06.044","article-title":"Longitudinal isolation of potent near-germline SARS-CoV-2-neutralizing antibodies from COVID-19 patients","volume":"182","author":"Kreer","year":"2020","journal-title":"Cell"},{"key":"2025063003524525500_vkaf033-B78","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1182\/blood.2021011871","article-title":"Aberrant glycosylation of anti-SARS-CoV-2 spike IgG is a prothrombotic stimulus for platelets","volume":"138","author":"Bye","year":"2021","journal-title":"Blood"},{"key":"2025063003524525500_vkaf033-B79","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abf8654","article-title":"High titers and low fucosylation of early human anti-SARS-CoV-2 IgG promote inflammation by alveolar macrophages","volume":"13","author":"Hoepel","year":"2021","journal-title":"Sci Transl Med"},{"key":"2025063003524525500_vkaf033-B80","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"2025063003524525500_vkaf033-B81","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"key":"2025063003524525500_vkaf033-B82","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/s41586-021-03653-6","article-title":"BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans","volume":"595","author":"Sahin","year":"2021","journal-title":"Nature"},{"key":"2025063003524525500_vkaf033-B83","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41586-020-2622-0","article-title":"SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness","volume":"586","author":"Corbett","year":"2020","journal-title":"Nature"},{"key":"2025063003524525500_vkaf033-B84","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41579-023-00878-2","article-title":"The evolution of SARS-CoV-2","volume":"21","author":"Markov","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"2025063003524525500_vkaf033-B85","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41586-021-03398-2","article-title":"Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7","volume":"593","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"2025063003524525500_vkaf033-B86","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1038\/s41591-021-01413-7","article-title":"Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals","volume":"27","author":"Kustin","year":"2021","journal-title":"Nat Med"},{"key":"2025063003524525500_vkaf033-B87","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.15585\/mmwr.mm7031e2","article-title":"Outbreak of SARS-CoV-2 infections, including COVID-19 vaccine breakthrough infections, associated with large public gatherings\u2014Barnstable County, Massachusetts, July 2021","volume":"70","author":"Brown","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025063003524525500_vkaf033-B88","doi-asserted-by":"crossref","first-page":"106230","DOI":"10.1016\/j.isci.2023.106230","article-title":"Evolution of increased positive charge on the SARS-CoV-2 spike protein may be adaptation to human transmission","volume":"26","author":"Cotten","year":"2023","journal-title":"iScience"},{"key":"2025063003524525500_vkaf033-B89","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s44298-024-00036-2","article-title":"Evolution at Spike protein position 519 in SARS-CoV-2 facilitated adaptation to humans","volume":"2","author":"Cereghino","year":"2024","journal-title":"NPJ Viruses"},{"key":"2025063003524525500_vkaf033-B90","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1038\/s41467-023-37826-w","article-title":"Generation of SARS-CoV-2 escape mutations by monoclonal antibody therapy","volume":"14","author":"Ragonnet-Cronin","year":"2023","journal-title":"Nat Commun"},{"key":"2025063003524525500_vkaf033-B91","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1038\/s41591-022-01882-4","article-title":"Drivers of adaptive evolution during chronic SARS-CoV-2 infections","volume":"28","author":"Harari","year":"2022","journal-title":"Nat Med"},{"key":"2025063003524525500_vkaf033-B92","doi-asserted-by":"crossref","first-page":"abm0829","DOI":"10.1126\/science.abm0829","article-title":"mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern","volume":"374","author":"Goel","year":"2021","journal-title":"Science"},{"key":"2025063003524525500_vkaf033-B93","doi-asserted-by":"crossref","first-page":"e0265621","DOI":"10.1128\/mBio.02656-21","article-title":"Previous infection combined with vaccination produces neutralizing antibodies with potency against SARS-CoV-2 variants","volume":"12","author":"Ibarrondo","year":"2021","journal-title":"mBio"},{"key":"2025063003524525500_vkaf033-B94"},{"key":"2025063003524525500_vkaf033-B95","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1056\/NEJMc2025179","article-title":"Rapid decay of anti-SARS-CoV-2 antibodies in persons with mild covid-19","volume":"383","author":"Ibarrondo","year":"2020","journal-title":"N Engl J Med"},{"key":"2025063003524525500_vkaf033-B96","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/s41591-020-0965-6","article-title":"Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections","volume":"26","author":"Long","year":"2020","journal-title":"Nature Medicine"},{"key":"2025063003524525500_vkaf033-B97","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/s41467-021-21111-9","article-title":"Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers","volume":"12","author":"Marot","year":"2021","journal-title":"Nat Commun"},{"key":"2025063003524525500_vkaf033-B98","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1126\/science.abd7728","article-title":"Robust neutralizing antibodies to SARS-CoV-2 infection persist for months","volume":"370","author":"Wajnberg","year":"2020","journal-title":"Science"},{"key":"2025063003524525500_vkaf033-B99","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abe0367","article-title":"Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients","volume":"5","author":"Iyer","year":"2020","journal-title":"Sci Immunol"},{"key":"2025063003524525500_vkaf033-B100","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abe5511","article-title":"Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients","volume":"5","author":"Isho","year":"2020","journal-title":"Sci Immunol"},{"key":"2025063003524525500_vkaf033-B101","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.4049\/jimmunol.2000839","article-title":"Antibody responses to SARS-CoV-2: let's stick to known knowns","volume":"205","author":"Baumgarth","year":"2020","journal-title":"J Immunol"},{"key":"2025063003524525500_vkaf033-B102","author":"Mandavilli"},{"key":"2025063003524525500_vkaf033-B103","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41586-021-03647-4","article-title":"SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans","volume":"595","author":"Turner","year":"2021","journal-title":"Nature"},{"key":"2025063003524525500_vkaf033-B104","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1017\/S0950268800048019","article-title":"The time course of the immune response to experimental coronavirus infection of man","volume":"105","author":"Callow","year":"1990","journal-title":"Epidemiol Infect"},{"key":"2025063003524525500_vkaf033-B105","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1038\/s41591-020-1083-1","article-title":"Seasonal coronavirus protective immunity is short-lasting","volume":"26","author":"Edridge","year":"2020","journal-title":"Nat Med"},{"key":"2025063003524525500_vkaf033-B106","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/aje\/kwx201","article-title":"Individual and population trajectories of influenza antibody titers over multiple seasons in a tropical country","volume":"187","author":"Zhao","year":"2018","journal-title":"Am J Epidemiol"},{"key":"2025063003524525500_vkaf033-B107","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S1473-3099(20)30764-7","article-title":"Genomic evidence for reinfection with SARS-CoV-2: a case study","volume":"21","author":"Tillett","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"2025063003524525500_vkaf033-B108","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1056\/NEJMoa2114228","article-title":"Waning Immunity after the BNT162b2 Vaccine in Israel","volume":"385","author":"Goldberg","year":"2021","journal-title":"N Engl J Med"},{"key":"2025063003524525500_vkaf033-B109","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abd2071","article-title":"Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome","volume":"5","author":"Weiskopf","year":"2020","journal-title":"Sci Immunol"},{"key":"2025063003524525500_vkaf033-B110","doi-asserted-by":"crossref","first-page":"108728","DOI":"10.1016\/j.celrep.2021.108728","article-title":"Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients","volume":"34","author":"Tan","year":"2021","journal-title":"Cell Rep"},{"key":"2025063003524525500_vkaf033-B111","doi-asserted-by":"crossref","first-page":"e145476","DOI":"10.1172\/JCI145476","article-title":"SARS-CoV-2-specific CD8+ T cell responses in convalescent COVID-19 individuals","volume":"131","author":"Kared","year":"2021","journal-title":"J Clin Invest"},{"key":"2025063003524525500_vkaf033-B112","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.cell.2020.09.038","article-title":"Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity","volume":"183","author":"Rydyznski Moderbacher","year":"2020","journal-title":"Cell"},{"key":"2025063003524525500_vkaf033-B113","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","article-title":"Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals","volume":"181","author":"Grifoni","year":"2020","journal-title":"Cell"},{"key":"2025063003524525500_vkaf033-B114","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/s41590-020-0782-6","article-title":"Broad and strong memory CD4(+) and CD8(+) T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19","volume":"21","author":"Peng","year":"2020","journal-title":"Nat Immunol"},{"key":"2025063003524525500_vkaf033-B115","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.cell.2020.08.017","article-title":"Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19","volume":"183","author":"Sekine","year":"2020","journal-title":"Cell"},{"key":"2025063003524525500_vkaf033-B116","doi-asserted-by":"crossref","first-page":"835830","DOI":"10.3389\/fimmu.2022.835830","article-title":"Dominant CD8(+) T cell nucleocapsid targeting in SARS-CoV-2 infection and broad spike targeting from vaccination","volume":"13","author":"Taus","year":"2022","journal-title":"Front Immunol"},{"key":"2025063003524525500_vkaf033-B117","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41590-021-01080-3","article-title":"Autocrine vitamin D signaling switches off pro-inflammatory programs of T(H)1 cells","volume":"23","author":"Chauss","year":"2022","journal-title":"Nat Immunol"},{"key":"2025063003524525500_vkaf033-B118","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.chom.2021.05.010","article-title":"SARS-CoV-2 human T cell epitopes: adaptive immune response against COVID-19","volume":"29","author":"Grifoni","year":"2021","journal-title":"Cell Host Microbe"},{"key":"2025063003524525500_vkaf033-B119","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41590-020-00808-x","article-title":"SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition","volume":"22","author":"Nelde","year":"2021","journal-title":"Nat Immunol"},{"key":"2025063003524525500_vkaf033-B120","first-page":"e12239","article-title":"Human leukocyte antigen (HLA) class I susceptible alleles against COVID-19 increase both infection and severity rate","volume":"12","author":"Ishii","year":"2020","journal-title":"Cureus"},{"key":"2025063003524525500_vkaf033-B121","doi-asserted-by":"crossref","first-page":"e00510-20","DOI":"10.1128\/JVI.00510-20","article-title":"Human leukocyte antigen susceptibility map for severe acute respiratory syndrome coronavirus 2","volume":"94","author":"Nguyen","year":"2020","journal-title":"J Virol"},{"key":"2025063003524525500_vkaf033-B122","doi-asserted-by":"crossref","first-page":"e143380","DOI":"10.1172\/JCI143380","article-title":"Recent endemic coronavirus infection is associated with less-severe COVID-19","volume":"131","author":"Sagar","year":"2021","journal-title":"J Clin Invest"},{"key":"2025063003524525500_vkaf033-B123","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.immuni.2021.04.006","article-title":"CD8(+) T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronaviruses","volume":"54","author":"Lineburg","year":"2021","journal-title":"Immunity"},{"key":"2025063003524525500_vkaf033-B124","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41586-023-06331-x","article-title":"A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection","volume":"620","author":"Augusto","year":"2023","journal-title":"Nature"},{"key":"2025063003524525500_vkaf033-B125","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1016\/j.cell.2022.05.022","article-title":"Humoral and cellular immune memory to four COVID-19 vaccines","volume":"185","author":"Zhang","year":"2022","journal-title":"Cell"},{"key":"2025063003524525500_vkaf033-B126","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41577-021-00578-z","article-title":"Immunological mechanisms of vaccine-induced protection against COVID-19 in humans","volume":"21","author":"Sadarangani","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"2025063003524525500_vkaf033-B127","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1093\/cid\/ciab555","article-title":"Humoral and cellular immune responses against SARS-CoV-2 variants and human coronaviruses after single BNT162b2 vaccination","volume":"73","author":"Stankov","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2025063003524525500_vkaf033-B128","doi-asserted-by":"crossref","first-page":"1100594","DOI":"10.3389\/fimmu.2023.1100594","article-title":"Persistent memory despite rapid contraction of circulating T cell responses to SARS-CoV-2 mRNA vaccination","volume":"14","author":"Taus","year":"2023","journal-title":"Front Immunol"},{"key":"2025063003524525500_vkaf033-B129","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1126\/science.abm0620","article-title":"SARS-CoV-2 vaccine protection and deaths among US veterans during 2021","volume":"375","author":"Cohn","year":"2022","journal-title":"Science"},{"key":"2025063003524525500_vkaf033-B130","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(21)00575-4","article-title":"Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study","volume":"397","author":"Hansen","year":"2021","journal-title":"Lancet"},{"key":"2025063003524525500_vkaf033-B131","doi-asserted-by":"crossref","first-page":"e1010211","DOI":"10.1371\/journal.ppat.1010211","article-title":"Longitudinal dynamics of SARS-CoV-2-specific cellular and humoral immunity after natural infection or BNT162b2 vaccination","volume":"17","author":"Almendro-Vazquez","year":"2021","journal-title":"PLoS Pathog"},{"key":"2025063003524525500_vkaf033-B132","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1093\/infdis\/jiab543","article-title":"Durability of SARS-CoV-2-specific T-cell responses at 12 months postinfection","volume":"224","author":"Lu","year":"2021","journal-title":"J Infect Dis"},{"key":"2025063003524525500_vkaf033-B133","doi-asserted-by":"crossref","first-page":"110235","DOI":"10.1016\/j.celrep.2021.110235","article-title":"Cellular and humoral functional responses after BNT162b2 mRNA vaccination differ longitudinally between naive and subjects recovered from COVID-19","volume":"38","author":"Lozano-Rodriguez","year":"2022","journal-title":"Cell Reports"},{"key":"2025063003524525500_vkaf033-B134","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.chom.2022.07.006","article-title":"Determinants of Spike infectivity, processing, and neutralization in SARS-CoV-2 Omicron subvariants BA.1 and BA.2","volume":"30","author":"Pastorio","year":"2022","journal-title":"Cell Host Microbe"},{"key":"2025063003524525500_vkaf033-B135","doi-asserted-by":"crossref","first-page":"e00647-20","DOI":"10.1128\/JVI.00647-20","article-title":"The nucleocapsid protein of SARS-CoV-2: a target for vaccine development","volume":"94","author":"Dutta","year":"2020","journal-title":"J Virol"},{"key":"2025063003524525500_vkaf033-B136","doi-asserted-by":"crossref","first-page":"22777","DOI":"10.1038\/s41598-021-02321-z","article-title":"Comparing the clinical efficacy of COVID-19 vaccines: a systematic review and network meta-analysis","volume":"11","author":"Rotshild","year":"2021","journal-title":"Sci Rep"},{"key":"2025063003524525500_vkaf033-B137","doi-asserted-by":"crossref","first-page":"e160898","DOI":"10.1172\/JCI160898","article-title":"NVX-CoV2373 vaccination induces functional SARS-CoV-2-specific CD4+ and CD8+ T cell responses","volume":"132","author":"Rydyznski Moderbacher","year":"2022","journal-title":"J Clin Invest"},{"key":"2025063003524525500_vkaf033-B138","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1056\/NEJMoa2116185","article-title":"Efficacy and safety of NVX-CoV2373 in Adults in the United States and Mexico","volume":"386","author":"Dunkle","year":"2022","journal-title":"N Engl J Med"},{"key":"2025063003524525500_vkaf033-B139","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00253-023-12927-0","article-title":"Caveats of chimpanzee ChAdOx1 adenovirus-vectored vaccines to boost anti-SARS-CoV-2 protective immunity in mice","volume":"108","author":"Cervantes-Torres","year":"2024","journal-title":"Appl Microbiol Biotechnol"},{"key":"2025063003524525500_vkaf033-B140","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/S1473-3099(22)00506-0","article-title":"Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"22","author":"Hardt","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"2025063003524525500_vkaf033-B141","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1001\/jama.2021.7517","article-title":"US case reports of cerebral venous sinus thrombosis with thrombocytopenia after Ad26.COV2.S vaccination, March 2 to April 21, 2021","volume":"325","author":"See","year":"2021","journal-title":"JAMA"},{"key":"2025063003524525500_vkaf033-B142","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/s41586-022-04462-1","article-title":"Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant","volume":"603","author":"Suzuki","year":"2022","journal-title":"Nature"},{"key":"2025063003524525500_vkaf033-B143","doi-asserted-by":"crossref","first-page":"713","DOI":"10.15585\/mmwr.mm7121e1","article-title":"Post-COVID conditions among adult COVID-19 survivors aged 18-64 and \u226565 years\u2014United States, March 2020-November 2021","volume":"71","author":"Bull-Otterson","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025063003524525500_vkaf033-B144","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.bbi.2021.12.020","article-title":"Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis","volume":"101","author":"Ceban","year":"2022","journal-title":"Brain Behav Immun"},{"key":"2025063003524525500_vkaf033-B145","author":"Centers for Disease Control and Prevention","year":"2024"},{"key":"2025063003524525500_vkaf033-B146"},{"key":"2025063003524525500_vkaf033-B147","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S2213-8587(22)00044-4","article-title":"Risks and burdens of incident diabetes in long COVID: a cohort study","volume":"10","author":"Xie","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2025063003524525500_vkaf033-B148","doi-asserted-by":"crossref","first-page":"1012668","DOI":"10.3389\/fneur.2022.1012668","article-title":"Characterization of autonomic symptom burden in long COVID: A global survey of 2,314 adults","volume":"13","author":"Larsen","year":"2022","journal-title":"Front Neurol"},{"key":"2025063003524525500_vkaf033-B149","doi-asserted-by":"crossref","first-page":"5104","DOI":"10.1038\/s41467-022-32507-6","article-title":"A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity","volume":"13","author":"Kedor","year":"2022","journal-title":"Nat Commun"},{"key":"2025063003524525500_vkaf033-B150","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41590-021-01113-x","article-title":"Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection","volume":"23","author":"Phetsouphanh","year":"2022","journal-title":"Nat Immunol"},{"key":"2025063003524525500_vkaf033-B151","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1093\/infdis\/jiab490","article-title":"Markers of immune activation and inflammation in individuals with postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection","volume":"224","author":"Peluso","year":"2021","journal-title":"J Infect Dis"},{"key":"2025063003524525500_vkaf033-B152","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41586-023-06651-y","article-title":"Distinguishing features of long COVID identified through immune profiling","volume":"623","author":"Klein","year":"2023","journal-title":"Nature"},{"key":"2025063003524525500_vkaf033-B153","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.cell.2022.01.014","article-title":"Multiple early factors anticipate post-acute COVID-19 sequelae","volume":"185","author":"Su","year":"2022","journal-title":"Cell"},{"key":"2025063003524525500_vkaf033-B154","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41586-021-03631-y","article-title":"Diverse functional autoantibodies in patients with COVID-19","volume":"595","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"2025063003524525500_vkaf033-B155","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1007\/s00296-022-05146-9","article-title":"Herpesvirus infections and post-COVID-19 manifestations: a pilot observational study","volume":"42","author":"Zubchenko","year":"2022","journal-title":"Rheumatol Int"},{"key":"2025063003524525500_vkaf033-B156","doi-asserted-by":"crossref","first-page":"e487","DOI":"10.1093\/cid\/ciac722","article-title":"Persistent circulating severe acute respiratory syndrome coronavirus 2 spike is associated with post-acute coronavirus disease 2019 sequelae","volume":"76","author":"Swank","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2025063003524525500_vkaf033-B157","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12879-022-07153-4","article-title":"Post-COVID-19 syndrome. SARS-CoV-2 RNA detection in plasma, stool, and urine in patients with persistent symptoms after COVID-19","volume":"22","author":"Tejerina","year":"2022","journal-title":"BMC Infect Dis"},{"key":"2025063003524525500_vkaf033-B158","doi-asserted-by":"crossref","first-page":"ofac464","DOI":"10.1093\/ofid\/ofac464","article-title":"Risk of long COVID in people infected with severe acute respiratory syndrome coronavirus 2 after 2 doses of a coronavirus disease 2019 vaccine: community-based, matched cohort study","volume":"9","author":"Ayoubkhani","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"2025063003524525500_vkaf033-B159","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1001\/jamainternmed.2023.0743","article-title":"Association of treatment with nirmatrelvir and the risk of post-COVID-19 condition","volume":"183","author":"Xie","year":"2023","journal-title":"JAMA Intern Med"}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/214\/6\/1095\/62857609\/vkaf033.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/214\/6\/1095\/62857609\/vkaf033.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T07:53:11Z","timestamp":1751269991000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/214\/6\/1095\/8105708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,3]]},"references-count":159,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,4,3]]},"published-print":{"date-parts":[[2025,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jimmun\/vkaf033","relation":{},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"value":"0022-1767","type":"print"},{"value":"1550-6606","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,6]]},"published":{"date-parts":[[2025,4,3]]}}}